In fact, knockdown of SHMT2 in MYC-dependent cells or in vivo suppression of SHMT2, in addition to reduction of cellular NADPH, increases ROS production, triggers hypoxia-induced cell death, and impairs tumor growth [100]. This evidence concerns the gene SHMT2 and neoplasm.